Can newborns who are carriers of deafness-causing genes receive preventive vaccinations?

Preventive vaccines usually do not contain ototoxic drugs, so newborns who carry genes for hereditary deafness can generally receive vaccinations.

Newborn carriers of deafness-causing genes refer to infants who carry genetic mutations that can lead to hearing loss, which is a type of congenital hereditary disorder. These genetic mutations may be inherited from parents and could potentially result in hearing impairment. Newborn carriers of deafness genes should avoid exposure to ototoxic medications in daily life, such as aminoglycoside drugs, to prevent triggering hearing loss. Since routine preventive vaccines typically do not contain ototoxic substances, newborn carriers of deafness genes can usually receive vaccinations safely, provided they are not experiencing any physical discomfort or other abnormalities. Vaccination will not adversely affect their health, so there is no need for excessive concern.

Newborn carriers of deafness genes may remain asymptomatic, but they should still take precautions to protect their hearing and avoid staying in excessively noisy environments. If any abnormalities are detected, prompt medical attention should be sought.